NCT07755735

Brief Summary

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the active fiber supplement or a matched placebo product, taken twice daily. Participants will complete questionnaires and provide waist and body composition measurements at Baseline, Week 4, Week 8, and Week 12. The primary outcomes include changes in overall gut health scores, waist circumference, and body composition. Secondary outcomes include participant-perceived effects on bloating, regularity, hydration, energy, and hair, skin, and nail support.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 26, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2026

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2026

Completed
Last Updated

August 10, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 5, 2026

Last Update Submit

August 5, 2026

Conditions

Outcome Measures

Primary Outcomes (9)

  • Change in Overall Gut Health Score

    Mean change in GSRS (Gastrointestinal Symptoms Rating Scale) total score from baseline as assessed via self-reported questionnaire

    Baseline, Week 4, Week 8, and Week 12

  • Change in Bowel Movement Quality

    Mean change in stool form and consistency as assessed via the Bristol Stool Scale self-reported questionnaire

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Hydration

    Mean change in self-reported hydration as assessed via self-reported questionnaire

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Bloating

    Mean change in self-reported bloating as assessed via self-reported questionnaire

    Baseline, Week 4, Week 8, and Week 12

  • Change in Waist Circumference

    Mean change in waist circumference from baseline as assessed via tape measure waist measurement

    Baseline, Week 4, Week 8, and Week 12

  • Change in Body Weight

    Mean change in body weight from baseline as assessed via Withings Smart Scale

    Baseline, Week 4, Week 8, and Week 12

  • Change in Muscle Mass

    Mean change in muscle mass from baseline as assessed via Withings Smart Scale

    Baseline, Week 4, Week 8, and Week 12

  • Change in Fat Mass

    Mean change in fat mass from baseline as assessed via Withings Smart Scale

    Baseline, Week 4, Week 8, and Week 12

  • Change in Visceral Fat Mass

    Mean change in visceral fat mass from baseline as assessed via Withings Smart Scale

    Baseline, Week 4, Week 8, and Week 12

Secondary Outcomes (7)

  • Change in Self-Reported Regularity

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Hydration

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Stool Feeling

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Energy Levels

    Baseline, Week 4, Week 8, and Week 12

  • Change in Self-Reported Hair

    Baseline, Week 4, Week 8, and Week 12

  • +2 more secondary outcomes

Study Arms (2)

Active Supplement

EXPERIMENTAL
Dietary Supplement: Active Supplement

Placebo Comparator

PLACEBO COMPARATOR
Dietary Supplement: Placebo Comparator

Interventions

Active SupplementDIETARY_SUPPLEMENT

Participants receive BelliWelli Daily Fiber + Probiotics supplement containing Collagen Peptides (Bovine) (2 g), Niacin as Niacinamide (7.5 mg), Magnesium as Magnesium Citrate (75 mg), Sodium as Sea Salt (75 mg), Potassium as Potassium Chloride (100 mg), Bacillus coagulans MTCC 5856 (10 mg / 1 billion CFU), and Acacia Fiber (4.0 g), consumed twice per day for 12 weeks.

Active Supplement
Placebo ComparatorDIETARY_SUPPLEMENT

Participants receive a taste- and appearance-matched placebo product containing Maltodextrin, Organic Cane Sugar, Natural Flavors, Citric Acid, Malic Acid, Silicon Dioxide, Stevia Leaf Extract, Beet Juice (color), and Fruit and Vegetable Juice (color), consumed twice per day for 12 weeks.

Placebo Comparator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be male or female
  • Be aged 18 or older
  • Experiencing issues regarding all of the following over the past 4 weeks: bloating, irregular bowel movements, and self-perceived poor gut health
  • Generally healthy - does not live with any uncontrolled chronic disease
  • Willing to discontinue any other supplements or herbal remedies that target gut or digestive health
  • Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health for the study duration
  • Willing to maintain current diet, sleep pattern, and activity levels for the duration
  • Resides in the United States
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration

You may not qualify if:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Anyone who is vegan and/or does not consume animal products for any reasons
  • Anyone unwilling to follow the study protocol
  • Anyone with a history of substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89101, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2026

First Posted

August 10, 2026

Study Start

August 26, 2025

Primary Completion

January 12, 2026

Study Completion

January 12, 2026

Last Updated

August 10, 2026

Record last verified: 2026-08

Locations